Meinl E, Krumbholz M, Derfuss T, Dewitt D,. Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis // J Neurol Sci. 274 (1 – 2). Ноември 2008. DOI:10.1016/j.jns.2008.06.032. с. 42 – 4.
Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview // Brain Pathol. 17 (2). Април 2007. DOI:10.1111/j.1750-3639.2007.00064.x. с. 210 – 8.
Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis // Neurology 68 (9). Февруари 2007. DOI:10.1212/01.wnl.0000250267.85698.7a. с. 634 – 42.
Fransson ME, Liljenfeldt LS, Fagius J, Tötterman TH, Loskog AS. The T-cell pool is anergized in patients with multiple sclerosis in remission // Immunology 126 (1). 2009. DOI:10.1111/j.1365-2567.2008.02881.x. с. 92 – 101.
Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis // J. Clin. Invest. 108 (8). Октомври 2001. DOI:10.1172/JCI12516. с. 1185 – 94.
Wulff H, Calabresi PA, Allie R, et al. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS // J. Clin. Invest. 111 (11). Юни 2003. DOI:10.1172/JCI16921. с. 1703 – 13.
Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis // N Engl J Med. 358 (7). Февруари 2008. DOI:10.1056/NEJMoa0706383. с. 676 – 88.
Pascual AM, Martínez-Bisbal MC, Boscá I, et al. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis // Neurology 69 (1). 2007. DOI:10.1212/01.wnl.0000265054.08610.12. с. 63 – 7.
Gray E, Thomas TL, Betmouni S, Scolding N, Love S. Elevated matrix metalloproteinase-9 and degradation of perineuronal nets in cerebrocortical multiple sclerosis plaques // J Neuropathol Exp Neurol. 67 (9). Септември 2008. DOI:10.1097/NEN.0b013e318183d003. с. 888 – 99.
Leussink VI, Lehmann HC, Meyer Zu Hörste G, Hartung HP, Stüve O, Kieseier BC. Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity // J Neurology 255 (9). Септември 2008. DOI:10.1007/s00415-008-0956-x. с. 1436 – 8.
Breij EC, Brink BP, Veerhuis R, et al. Homogeneity of active demyelinating lesions in established multiple sclerosis // Ann Neurol 63 (1). 2008. DOI:10.1002/ana.21311. с. 16 – 25.
Mahad D, Ziabreva I, Lassmann H, Turnbull D. Mitochondrial defects in acute multiple sclerosis lesions // Brain: a journal of neurology 131 (Pt 7). 2008. DOI:10.1093/brain/awn105. с. 1722 – 35.